An Overview of the Ongoing Clinical Issues of COVID-19

Pediatric Annals
|February 12, 2021
PubMed

Insights

Childhood COVID-19 cases are increasing, with teens most affected. Early containment and vaccination are crucial to control the spread of the virus and prevent MIS-C.

Area of Science:

  • Pediatric Infectious Diseases
  • Public Health
  • Virology

Background:

  • Childhood cases of coronavirus disease 2019 (COVID-19) are rising globally.
  • Most pediatric infections stem from adult household contacts.
  • Children can be asymptomatic, pre-symptomatic, or symptomatic, with fever, cough, and dyspnea being common.

Purpose of the Study:

  • To summarize the current understanding of COVID-19 in children.
  • To highlight the risks of multisystem inflammatory syndrome in children (MIS-C).
  • To discuss diagnostic approaches and prevention strategies.

Main Methods:

  • Review of current literature on pediatric COVID-19.
  • Analysis of case demographics and clinical presentations.
  • Discussion of diagnostic testing (NAAT, serology) and management.

Main Results:

  • Nearly one-third of US pediatric COVID-19 cases were in adolescents aged 15-17 years.
  • The risk of vertical transmission from infected mothers to newborns is low (2%).
  • Multisystem inflammatory syndrome in children (MIS-C) is a significant postinfectious complication.

Conclusions:

  • Nucleic acid amplification testing (NAAT) is the primary diagnostic tool for SARS-CoV-2.
  • Serology aids diagnosis in specific clinical scenarios, including MIS-C assessment.
  • Effective containment strategies and universal vaccination are essential to mitigate the pandemic's impact on children.

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.6K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
585
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.0K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.9K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.0K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.2K